Market Value500,452,000
Total Holdings46
File Date2020-08-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
CHAQ.U / Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of , and one
FUSN / Fusion Pharmaceuticals Inc.
GBIO / Generation Bio Co.
OBSV / ObsEva SA.
RETA / Reata Pharmaceuticals Inc - Class A
AKUS / Akouos Inc
AKBA / Akebia Therapeutics, Inc.
AMTI / Applied Molecular Transport Inc.
ARYBU / ARYA Sciences Acquisition Corp II
CALT / Calliditas Therapeutics AB (publ) - Depositary Receipt (Common Stock)
US74257L1089 / Principia Biopharma Inc.
STRO / Sutro Biopharma, Inc.
XFOR / X4 Pharmaceuticals, Inc.
TXG / 10x Genomics, Inc.
ABBV / AbbVie Inc.
BMY / Bristol-Myers Squibb Company
CRSP / CRISPR Therapeutics AG
/ Immunomedics, Inc.
MRNA / Moderna, Inc.
TRIL / Trillium Therapeutics Inc
US62857M1053 / MyoKardia, Inc.
VRTX / Vertex Pharmaceuticals Incorporated
NERV / Minerva Neurosciences, Inc.
SAGE / Sage Therapeutics, Inc.
110122157 / Bristol Meyers Squibb CVR Exp. 12/31/2020
APTO / Aptose Biosciences Inc.
PCVX / Vaxcyte, Inc.
SWTX / SpringWorks Therapeutics, Inc.
MTEM / Molecular Templates, Inc.
IOVA / Iovance Biotherapeutics, Inc.
GBT / Global Blood Therapeutics Inc.
VSTM / Verastem, Inc.
SELB / Selecta Biosciences Inc
FULC / Fulcrum Therapeutics, Inc.
VINC / Vincerx Pharma, Inc.
ZYME / Zymeworks Inc.
SVRA / Savara Inc.
ALNY / Alnylam Pharmaceuticals, Inc.
KALV / KalVista Pharmaceuticals, Inc.
LUMO / Lumos Pharma, Inc.
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
CLDX / Celldex Therapeutics, Inc.
IGMS / IGM Biosciences, Inc.
FMTX / Forma Therapeutics Holdings Inc
BDTX / Black Diamond Therapeutics, Inc.
FATE / Fate Therapeutics, Inc.
TGTX / TG Therapeutics, Inc.
ZGNX / Zogenix Inc
PASG / Passage Bio, Inc.
BLU / Bellus Health Inc
MRTX / Mirati Therapeutics, Inc.
ARNA / Arena Pharmaceuticals Inc
RAPT / RAPT Therapeutics, Inc.
FOLD / Amicus Therapeutics, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
KROS / Keros Therapeutics, Inc.
BTAI / BioXcel Therapeutics, Inc.
KRTX / Karuna Therapeutics, Inc.
MRTX / Mirati Therapeutics, Inc. Call
RVMD / Revolution Medicines, Inc.
IMVT / Immunovant, Inc.
RPTX / Repare Therapeutics Inc.
ISEE / IVERIC bio Inc
PLRX / Pliant Therapeutics, Inc.
BPMC / Blueprint Medicines Corporation
CYTK / Cytokinetics, Incorporated
BNTX / BioNTech SE - Depositary Receipt (Common Stock)
RNA / Avidity Biosciences, Inc.
ETNB / 89bio, Inc.
RCKT / Rocket Pharmaceuticals, Inc.
LRMR / Larimar Therapeutics, Inc.
SRPT / Sarepta Therapeutics, Inc.
APLT / Applied Therapeutics, Inc.